Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent versus continuous oxytocin during active labor induction
IRCT20230221057483N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Apr 2023
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, double-blind trial of oxytocin in induced labor (2 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoint: Time of oxytocin injection. Started Apr 2023; status: completed.
02
Drugs
oxytocin
03
Conditions
induced labor
Beyond the preview
Go deeper on IRCT20230221057483N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230221057483N1.